tedisamil has been researched along with Myocardial Ischemia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, TD; Sarraf, G; Walker, MJ | 1 |
Curtis, MJ; Hearse, DJ; Rees, SA; Tsuchihashi, K | 1 |
Appleby, SD; Baskin, EP; Gehret, JR; King, SW; Kothstein, T; Lynch, JJ; Remy, DC; Stupienski, RF; Wallace, AA | 1 |
Mitrovic, V; Oehm, E; Pitschner, HF; Schlepper, M; Strasser, R | 1 |
Abraham, S; McLarnon, JG; Walker, MJ; Xu, R | 1 |
Abreu, JN; Borlak, J; Driscoll, EM; Friedrichs, GS; Lucchesi, BR | 1 |
Fickova, M; Gabauer, I; Manoach, M; Okruhlicova, L; Pancza, D; Ravingerova, T; Slezak, J; Tribulova, N | 1 |
Hamm, C; Miskovic, A; Mitrovic, V; Pitschner, H; Strau, M; Thormann, J | 1 |
2 trial(s) available for tedisamil and Myocardial Ischemia
Article | Year |
---|---|
[The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease].
Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Catheterization; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Potassium Channels | 1996 |
Hemodynamic, antiischemic, and neurohumoral effects of tedisamil and atenolol in patients with coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Bridged Bicyclo Compounds, Heterocyclic; Catecholamines; Chromatography, High Pressure Liquid; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia | 2000 |
6 other study(ies) available for tedisamil and Myocardial Ischemia
Article | Year |
---|---|
Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.
Topics: Animals; Anti-Asthmatic Agents; Arrhythmias, Cardiac; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Injections, Intravenous; Lidocaine; Myocardial Ischemia; Rats | 2003 |
Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Cromakalim; Cyclopropanes; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Heart Rate; Hemodynamics; In Vitro Techniques; Injections, Intravenous; Male; Myocardial Ischemia; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vasodilator Agents; Ventricular Fibrillation | 1993 |
Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
Topics: Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dogs; Electrocardiography; Female; Ferrets; Heart; Hemodynamics; In Vitro Techniques; Male; Myocardial Ischemia; Papillary Muscles; Potassium Channels; Refractory Period, Electrophysiological | 1995 |
KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Electric Stimulation; Electrocardiography; Heart Rate; Male; Myocardial Ischemia; Potassium Channels; Rats; Rats, Sprague-Dawley; Sodium Channels | 1997 |
Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Topics: Administration, Oral; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cardiotonic Agents; Cyclopropanes; Death, Sudden, Cardiac; Dogs; Electric Stimulation; Electrophysiology; Heart Rate; Heart Ventricles; Male; Myocardial Ischemia; Time Factors; Ventricular Fibrillation; Ventricular Function | 1998 |
Modulation of cAMP level by tedisamil in guinea pig heart.
Topics: Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds, Heterocyclic; Cyclic AMP; Cyclopropanes; Guinea Pigs; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardium | 2000 |